Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

OPTIMIzing muScle Preservation in paTients wIth Cirrhosis

Authors not listed

University of Kansas Medical Center · 2022

Abstract

Patients with obesity and cirrhosis benefit from weight loss but are prone to sarcopenia (loss of muscle mass, strength, and function). This study proposes to test a specialized weight loss program Alternative-day Modified Fasting (ADMF) designed to promote weight loss and preserve skeletal muscle mass, strength, and function in patients with both Child-Pugh (CP) class A cirrhosis and obesity. This study will compare the effectiveness of the ADMF to Continuous Energy Restriction (CER) for 24-weeks. Both arms will receive a high-protein, high-BCAA diet, a late-night snack, supervised aerobic and resistance exercise, increased physical activity through self-monitoring, and group behavioral counseling. The primary aim of this trial is to evaluate the feasibility and acceptability of ADMF and CER for 6 months in patients with cirrhosis and obesity. The secondary aim is to compare changes in body composition in both diets.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-04 MST

Cite this

APA
Anonymous. (2022). OPTIMIzing muScle Preservation in paTients wIth Cirrhosis. <em>University of Kansas Medical Center</em>. https://clinicaltrials.gov/study/NCT05367596
Vancouver
Anonymous. OPTIMIzing muScle Preservation in paTients wIth Cirrhosis. University of Kansas Medical Center. 2022.
BibTeX
@misc{anon2022OPTIMI, title = {OPTIMIzing muScle Preservation in paTients wIth Cirrhosis}, author = {Anonymous}, journal = {University of Kansas Medical Center}, year = {2022}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings